Bio-Banking Human Samples - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244162

Publication Date:

November 4, 2024

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Bio-Banking Human Samples was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Bio-Banking Human Samples was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio-Banking Human Samples was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Bio-Banking Human Samples was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Bio-Banking Human Samples include Brooks Life Science, Tecan Group, Promega, Hamilton, BD, Merck, DNA Genotek, Biolife Solutions and QIAGEN, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bio-Banking Human Samples, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bio-Banking Human Samples by region & country, by Type, and by Application.
The Bio-Banking Human Samples market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Banking Human Samples.
麻豆原创 Segmentation
By Company
Brooks Life Science
Tecan Group
Promega
Hamilton
BD
Merck
DNA Genotek
Biolife Solutions
QIAGEN
Greiner Bio One
Shanghai Genext Medical Techology Co Ltd
TTP Labtech Ltd
BioRep
Beckman Coulter
Segment by Type:
Population Based Biobank
Disease-Oriented Biobank
Segment by Application
Biotherapy
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bio-Banking Human Samples manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Bio-Banking Human Samples in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Bio-Banking Human Samples in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Bio-Banking Human Samples Product Introduction
1.2 Global Bio-Banking Human Samples 麻豆原创 Size Forecast
1.3 Bio-Banking Human Samples 麻豆原创 Trends & Drivers
1.3.1 Bio-Banking Human Samples Industry Trends
1.3.2 Bio-Banking Human Samples 麻豆原创 Drivers & Opportunity
1.3.3 Bio-Banking Human Samples 麻豆原创 Challenges
1.3.4 Bio-Banking Human Samples 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bio-Banking Human Samples Players Revenue Ranking (2023)
2.2 Global Bio-Banking Human Samples Revenue by Company (2019-2024)
2.3 Key Companies Bio-Banking Human Samples Manufacturing Base Distribution and Headquarters
2.4 Key Companies Bio-Banking Human Samples Product Offered
2.5 Key Companies Time to Begin Mass Production of Bio-Banking Human Samples
2.6 Bio-Banking Human Samples 麻豆原创 Competitive Analysis
2.6.1 Bio-Banking Human Samples 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Bio-Banking Human Samples Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-Banking Human Samples as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Population Based Biobank
3.1.2 Disease-Oriented Biobank
3.2 Global Bio-Banking Human Samples Sales Value by Type
3.2.1 Global Bio-Banking Human Samples Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bio-Banking Human Samples Sales Value, by Type (2019-2030)
3.2.3 Global Bio-Banking Human Samples Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotherapy
4.1.2 Research Institutions
4.2 Global Bio-Banking Human Samples Sales Value by Application
4.2.1 Global Bio-Banking Human Samples Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bio-Banking Human Samples Sales Value, by Application (2019-2030)
4.2.3 Global Bio-Banking Human Samples Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Bio-Banking Human Samples Sales Value by Region
5.1.1 Global Bio-Banking Human Samples Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bio-Banking Human Samples Sales Value by Region (2019-2024)
5.1.3 Global Bio-Banking Human Samples Sales Value by Region (2025-2030)
5.1.4 Global Bio-Banking Human Samples Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Bio-Banking Human Samples Sales Value, 2019-2030
5.2.2 North America Bio-Banking Human Samples Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Bio-Banking Human Samples Sales Value, 2019-2030
5.3.2 Europe Bio-Banking Human Samples Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Bio-Banking Human Samples Sales Value, 2019-2030
5.4.2 Asia Pacific Bio-Banking Human Samples Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Bio-Banking Human Samples Sales Value, 2019-2030
5.5.2 South America Bio-Banking Human Samples Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Bio-Banking Human Samples Sales Value, 2019-2030
5.6.2 Middle East & Africa Bio-Banking Human Samples Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bio-Banking Human Samples Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bio-Banking Human Samples Sales Value
6.3 United States
6.3.1 United States Bio-Banking Human Samples Sales Value, 2019-2030
6.3.2 United States Bio-Banking Human Samples Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bio-Banking Human Samples Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bio-Banking Human Samples Sales Value, 2019-2030
6.4.2 Europe Bio-Banking Human Samples Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bio-Banking Human Samples Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bio-Banking Human Samples Sales Value, 2019-2030
6.5.2 China Bio-Banking Human Samples Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bio-Banking Human Samples Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bio-Banking Human Samples Sales Value, 2019-2030
6.6.2 Japan Bio-Banking Human Samples Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bio-Banking Human Samples Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bio-Banking Human Samples Sales Value, 2019-2030
6.7.2 South Korea Bio-Banking Human Samples Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bio-Banking Human Samples Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bio-Banking Human Samples Sales Value, 2019-2030
6.8.2 Southeast Asia Bio-Banking Human Samples Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bio-Banking Human Samples Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bio-Banking Human Samples Sales Value, 2019-2030
6.9.2 India Bio-Banking Human Samples Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bio-Banking Human Samples Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Brooks Life Science
7.1.1 Brooks Life Science Profile
7.1.2 Brooks Life Science Main Business
7.1.3 Brooks Life Science Bio-Banking Human Samples Products, Services and Solutions
7.1.4 Brooks Life Science Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.1.5 Brooks Life Science Recent Developments
7.2 Tecan Group
7.2.1 Tecan Group Profile
7.2.2 Tecan Group Main Business
7.2.3 Tecan Group Bio-Banking Human Samples Products, Services and Solutions
7.2.4 Tecan Group Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.2.5 Tecan Group Recent Developments
7.3 Promega
7.3.1 Promega Profile
7.3.2 Promega Main Business
7.3.3 Promega Bio-Banking Human Samples Products, Services and Solutions
7.3.4 Promega Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.3.5 Hamilton Recent Developments
7.4 Hamilton
7.4.1 Hamilton Profile
7.4.2 Hamilton Main Business
7.4.3 Hamilton Bio-Banking Human Samples Products, Services and Solutions
7.4.4 Hamilton Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.4.5 Hamilton Recent Developments
7.5 BD
7.5.1 BD Profile
7.5.2 BD Main Business
7.5.3 BD Bio-Banking Human Samples Products, Services and Solutions
7.5.4 BD Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.5.5 BD Recent Developments
7.6 Merck
7.6.1 Merck Profile
7.6.2 Merck Main Business
7.6.3 Merck Bio-Banking Human Samples Products, Services and Solutions
7.6.4 Merck Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.6.5 Merck Recent Developments
7.7 DNA Genotek
7.7.1 DNA Genotek Profile
7.7.2 DNA Genotek Main Business
7.7.3 DNA Genotek Bio-Banking Human Samples Products, Services and Solutions
7.7.4 DNA Genotek Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.7.5 DNA Genotek Recent Developments
7.8 Biolife Solutions
7.8.1 Biolife Solutions Profile
7.8.2 Biolife Solutions Main Business
7.8.3 Biolife Solutions Bio-Banking Human Samples Products, Services and Solutions
7.8.4 Biolife Solutions Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.8.5 Biolife Solutions Recent Developments
7.9 QIAGEN
7.9.1 QIAGEN Profile
7.9.2 QIAGEN Main Business
7.9.3 QIAGEN Bio-Banking Human Samples Products, Services and Solutions
7.9.4 QIAGEN Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.9.5 QIAGEN Recent Developments
7.10 Greiner Bio One
7.10.1 Greiner Bio One Profile
7.10.2 Greiner Bio One Main Business
7.10.3 Greiner Bio One Bio-Banking Human Samples Products, Services and Solutions
7.10.4 Greiner Bio One Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.10.5 Greiner Bio One Recent Developments
7.11 Shanghai Genext Medical Techology Co Ltd
7.11.1 Shanghai Genext Medical Techology Co Ltd Profile
7.11.2 Shanghai Genext Medical Techology Co Ltd Main Business
7.11.3 Shanghai Genext Medical Techology Co Ltd Bio-Banking Human Samples Products, Services and Solutions
7.11.4 Shanghai Genext Medical Techology Co Ltd Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.11.5 Shanghai Genext Medical Techology Co Ltd Recent Developments
7.12 TTP Labtech Ltd
7.12.1 TTP Labtech Ltd Profile
7.12.2 TTP Labtech Ltd Main Business
7.12.3 TTP Labtech Ltd Bio-Banking Human Samples Products, Services and Solutions
7.12.4 TTP Labtech Ltd Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.12.5 TTP Labtech Ltd Recent Developments
7.13 BioRep
7.13.1 BioRep Profile
7.13.2 BioRep Main Business
7.13.3 BioRep Bio-Banking Human Samples Products, Services and Solutions
7.13.4 BioRep Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.13.5 BioRep Recent Developments
7.14 Beckman Coulter
7.14.1 Beckman Coulter Profile
7.14.2 Beckman Coulter Main Business
7.14.3 Beckman Coulter Bio-Banking Human Samples Products, Services and Solutions
7.14.4 Beckman Coulter Bio-Banking Human Samples Revenue (US$ Million) & (2019-2024)
7.14.5 Beckman Coulter Recent Developments
8 Industry Chain Analysis
8.1 Bio-Banking Human Samples Industrial Chain
8.2 Bio-Banking Human Samples Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bio-Banking Human Samples Sales Model
8.5.2 Sales Channel
8.5.3 Bio-Banking Human Samples Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Brooks Life Science
Tecan Group
Promega
Hamilton
BD
Merck
DNA Genotek
Biolife Solutions
QIAGEN
Greiner Bio One
Shanghai Genext Medical Techology Co Ltd
TTP Labtech Ltd
BioRep
Beckman Coulter

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.